Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Transplantation

Free Subscription Articles published in Transpl Int Retrieve available abstracts of 90 articles: HTML format Text format

Single Articles

June 2018
1. VINAIXA C, Selzner N, Berenguer M
   Fat and liver transplantation: clinical implications.
   Transpl Int. 2018 Jun 8. doi: 10.1111/tri.13288.
   PubMed     Text format     Abstract available
   
   
   
2. QUINTINI C, Diago Uso T, Fujiki M, Eghtesad B, et al
   Liver "lobe neutrality" in the era of donor safety. Could "safe" be safer?
   Transpl Int. 2018;31:588-589.
   PubMed     Text format    
   
   
   May 2018
3. SANADA Y, Katano T, Hirata Y, Yamada N, et al
   Interventional radiology treatment for vascular and biliary complications following pediatric living donor liver transplantation.
   Transpl Int. 2018 May 31. doi: 10.1111/tri.13285.
   PubMed     Text format     Abstract available
   
   
   
4. MAKKI K, Chorasiya V, Srivastava A, Singhal A, et al
   Analysis of caudate lobe biliary anatomy and its implications in living donor liver transplantation - a single centre prospective study.
   Transpl Int. 2018 May 2. doi: 10.1111/tri.13272.
   PubMed     Text format     Abstract available
   
   
   April 2018
5. LOH PS, Gilder F, Klinck J
   Intra-operative cell salvage and sickle cell trait in liver transplantation: time to re-consider?
   Transpl Int. 2018 Apr 19. doi: 10.1111/tri.13268.
   PubMed     Text format     Abstract available
   
   
   March 2018
6. MANZIA TM, Lai Q, Iesari S, Perera MTPR, et al
   Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multi centre cohort study.
   Transpl Int. 2018 Mar 23. doi: 10.1111/tri.13153.
   PubMed     Text format     Abstract available
   
   
   
7. ANGELICO R, Nardi A, Adam R, Nadalin S, et al
   Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry (ELTR).
   Transpl Int. 2018 Mar 5. doi: 10.1111/tri.13147.
   PubMed     Text format     Abstract available
   
   
   
8. AGUILERA V, Di Maira T, Conde I, Fornes-Ferrer V, et al
   Cytomegalovirus reactivation in liver transplant recipients due to HCV cirrhosis is associated with higher cardiovascular risk.
   Transpl Int. 2018 Mar 1. doi: 10.1111/tri.13145.
   PubMed     Text format     Abstract available
   
   
   February 2018
9. BLOK JJ, de Boer JD, Putter H, Rogiers X, et al
   The center effect in liver transplantation in the Eurotransplant region.
   Transpl Int. 2018 Feb 6. doi: 10.1111/tri.13129.
   PubMed     Text format     Abstract available
   
   
   January 2018
10. POMMERGAARD HC, Rostved AA, Adam R, Thygesen LC, et al
    Locoregional treatments before liver transplantation for hepatocellular carcinoma: A study from the European Liver Transplant Registry.
    Transpl Int. 2018 Jan 30. doi: 10.1111/tri.13123.
    PubMed     Text format     Abstract available
    
    
    
11. BIELEN R, Robaeys G, Schelfhout S, Monbaliu D, et al
    Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues for patients at risk for renal failure after liver transplantation.
    Transpl Int. 2018 Jan 23. doi: 10.1111/tri.13112.
    PubMed     Text format     Abstract available
    
    
    November 2017
12. SERPER M, Reese P, Patzer R, Levitsky J, et al
    The Prevalence, Risk Factors, and Outcomes of Medication Tradeoffs in Kidney and Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2017 Nov 25. doi: 10.1111/tri.13098.
    PubMed     Text format     Abstract available
    
    
    
13. GOET JC, Hansen BE, Tieleman M, van Hoek B, et al
    Current policy for allocation of donor livers in the Netherlands advantages Primary Sclerosing Cholangitis patients on the liver transplantation waiting list - a retrospective study.
    Transpl Int. 2017 Nov 18. doi: 10.1111/tri.13097.
    PubMed     Text format     Abstract available
    
    
    
14. KARTHIK SV, Quak SH, Aw MM
    Endoscopic retrograde cholangio-pancreatography in the management of biliary complications after Paediatric liver transplantation.
    Transpl Int. 2017 Nov 11. doi: 10.1111/tri.13091.
    PubMed     Text format     Abstract available
    
    
    
15. LANDI F, de'Angelis N, Sepulveda A, Martinez-Perez A, et al
    Endoscopic treatment of anastomotic biliary stricture after adult deceased donor liver transplantation with multiple plastic stents versus self-expandable metal stents: a systematic review and meta-analysis.
    Transpl Int. 2017 Nov 1. doi: 10.1111/tri.13089.
    PubMed     Text format     Abstract available
    
    
    September 2017
16. VAN VUGT JLA, Buettner S, Alferink LJM, Bossche N, et al
    Low Skeletal Muscle Mass is Associated with Increased Hospital Costs in Patients with Cirrhosis Listed for Liver Transplantation.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13048.
    PubMed     Text format     Abstract available
    
    
    
17. GILBO N, Van Praet L, Jochmans I, Sainz-Barriga M, et al
    Preoperative Trans-Catheter Arterial Chemo Embolization Increases Hepatic Artery Thrombosis after Liver Transplantation - a retrospective study.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13046.
    PubMed     Text format     Abstract available
    
    
    August 2017
18. QUINTERO J, Juamperez J, Ortega J, Molino JA, et al
    Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients.
    Transpl Int. 2017 Aug 21. doi: 10.1111/tri.13037.
    PubMed     Text format     Abstract available
    
    
    
19. PEZZATI D, Hassan A, Buccini L, Liu Q, et al
    Liver transplantation with geriatric liver allograft in the US: A matter of epidemiology or of outcome requirements?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13013.
    PubMed     Text format     Abstract available
    
    
    July 2017
20. ARAVINTHAN AAD, Barbas AS, Doyle AC, Tazari M, et al
    Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
    Transpl Int. 2017 Jul 7. doi: 10.1111/tri.13008.
    PubMed     Text format     Abstract available
    
    
    June 2017
21. SATAPATHY SK, Jiang Y, Eason JD, Kedia SK, et al
    Cardiovascular Mortality among Liver Transplant Recipients with Nonalcoholic Steatohepatitis (NASH) in the United States.
    Transpl Int. 2017 Jun 16. doi: 10.1111/tri.13001.
    PubMed     Text format     Abstract available
    
    
    
22. WHITEHOUSE GP, Hope A, Sanchez-Fueyo A
    Regulatory T Cell Therapy in Liver Transplantation.
    Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12998.
    PubMed     Text format     Abstract available
    
    
    
23. SALCEDO M, Prieto M, Castells L, Pascasio JM, et al
    Efficacy and safety of daclatasvir-based antiviral therapy in HCV recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multi-centre cohort study.
    Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12999.
    PubMed     Text format     Abstract available
    
    
    
24. TAKAHASHI K, Nagai S, Puchakayala KG, Safwan M, et al
    Prediction of Biliary Anastomotic Stricture after Deceased Donor Liver Transplantation: The Impact of Platelet Counts.
    Transpl Int. 2017 Jun 12. doi: 10.1111/tri.12996.
    PubMed     Text format     Abstract available
    
    
    May 2017
25. BADAWY A, Hamaguchi Y, Seo S, Kaido T, et al
    Evaluation of Safety of Concomitant Splenectomy in Living Donor Liver Transplantation.
    Transpl Int. 2017 May 17. doi: 10.1111/tri.12985.
    PubMed     Text format     Abstract available
    
    
    
26. METSELAAR HJ, van den Berg A, Coenraad MJ
    Why we need fairer allocation rules for patients with hepatocellular carcinoma awaiting a liver transplant.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12980.
    PubMed     Text format     Abstract available
    
    
    April 2017
27. ALVER SK, Lorenz DJ, Washburn K, Marvin MR, et al
    Comparison of two equivalent MELD scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12967.
    PubMed     Text format     Abstract available
    
    
    
28. ALFERINK LJ, Oey RC, Hansen BE, Polak WG, et al
    The impact of infections on delisting patients from the liver transplantation waiting list.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12965.
    PubMed     Text format     Abstract available
    
    
    
29. YASSEN AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, et al
    Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A Prospective Randomized Controlled Trial.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12968.
    PubMed     Text format     Abstract available
    
    
    
30. PEZZATI D, Ghinolfi D, Lai Q, Cirillo G, et al
    Use of donors with genitourinary malignancies for liver transplantation: A calculated risk?
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12962.
    PubMed     Text format     Abstract available
    
    
    March 2017
31. SGARABOTTO D, Fasolato S, Vianello F, Vittadello F, et al
    Antibiotic prophylaxis for preventing post orthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?
    Transpl Int. 2017 Mar 23. doi: 10.1111/tri.12955.
    PubMed     Text format     Abstract available
    
    
    
32. HARRIES L, Schrem H, Stahmeyer JT, Krauth C, et al
    High Resource Utilization in Liver Transplantation - How Strongly differ Costs between the Care Sectors and What are the Main Cost Drivers?
    Transpl Int. 2017 Mar 11. doi: 10.1111/tri.12950.
    PubMed     Text format     Abstract available
    
    
    
33. ROLLER J, Glanemann M
    Keep the pressure! Correlation of hemodynamic instability after reperfusion and severity of acute kidney injury following liver transplantation.
    Transpl Int. 2017 Mar 7. doi: 10.1111/tri.12948.
    PubMed     Text format     Abstract available
    
    
    
34. DE BOER JD, Kopp WH, Ooms K, Haase-Kromwijk BJ, et al
    Abdominal organ procurement in the Netherlands - an analysis of quality and clinical impact.
    Transpl Int. 2017;30:288-294.
    PubMed     Text format     Abstract available
    
    
    February 2017
35. SCHNITZBAUER AA, Bechstein WO
    Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!
    Transpl Int. 2017 Feb 22. doi: 10.1111/tri.12942.
    PubMed     Text format     Abstract available
    
    
    
36. GROSSI PA
    Liver Transplantation from donors with positive blood cultures: increased risk of graft failure or opportunity to expand the donor pool?
    Transpl Int. 2017 Feb 20. doi: 10.1111/tri.12939.
    PubMed     Text format     Abstract available
    
    
    January 2017
37. BURRA P, Zanetto A
    Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.
    Transpl Int. 2017 Jan 19. doi: 10.1111/tri.12917.
    PubMed     Text format     Abstract available
    
    
    
38. DE BOER JD, Koopman JJ, Metselaar HJ, Braat AE, et al
    Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant.
    Transpl Int. 2017 Jan 6. doi: 10.1111/tri.12914.
    PubMed     Text format     Abstract available
    
    
    
39. D'AGNOLO HM, Kievit W, van Munster KN, van der Laan JJ, et al
    Center is an important indicator for choice of invasive therapy in polycystic liver disease.
    Transpl Int. 2017;30:76-82.
    PubMed     Text format     Abstract available
    
    
    December 2016
40. HERZER K, Welzel TM, Spengler U, Hinrichsen H, et al
    Real-World Experience With Daclatasvir Plus Sofosbuvir +/- Ribavirin for Post-Liver Transplant HCV Recurrence and Severe Liver Disease.
    Transpl Int. 2016 Dec 24. doi: 10.1111/tri.12910.
    PubMed     Text format     Abstract available
    
    
    November 2016
41. DE MARTIN E, Antonini TM, Coilly A, Pittau G, et al
    HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898.
    PubMed     Text format     Abstract available
    
    
    
42. O'LEARY JG, Fontana RJ, Brown K, Burton JR Jr, et al
    Efficacy and Safety of Simeprevir and Sofosbuvir With and Without Ribavirin in Subjects With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant: The Randomized GALAXY Study.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12896.
    PubMed     Text format     Abstract available
    
    
    
43. HUAMAN MA, Vilchez V, Mei X, Shah MB, et al
    Decreased Graft Survival in Liver Transplant Recipients of Donors with Positive Blood Cultures: A review of the UNOS dataset.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12900.
    PubMed     Text format     Abstract available
    
    
    
44. KALISVAART M, de Haan JE, Hesselink DA, Polak WG, et al
    The Postreperfusion Syndrome Is Associated With Acute Kidney Injury Following Donation After Brain Death Liver Transplantation.
    Transpl Int. 2016 Nov 19. doi: 10.1111/tri.12891.
    PubMed     Text format     Abstract available
    
    
    October 2016
45. VOUTILAINEN SH, Kosola SK, Tervahartiala TI, Sorsa TA, et al
    Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients.
    Transpl Int. 2016 Oct 23. doi: 10.1111/tri.12879.
    PubMed     Text format     Abstract available
    
    
    
46. SINGAL AK, Fang X, Kaif M, Hasanin M, et al
    Primary Biliary Cirrhosis Has High Wait List Mortality Among Patients Listed For Liver Transplantation.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12877.
    PubMed     Text format     Abstract available
    
    
    
47. STINE JG, Argo CK, Pelletier SJ, Maluf DG, et al
    Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.
    Transpl Int. 2016 Oct 6. doi: 10.1111/tri.12855.
    PubMed     Text format     Abstract available
    
    
    September 2016
48. NEVIERE R, Trinh-Duc P, Hulo S, Edme JL, et al
    Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantion.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12861.
    PubMed     Text format     Abstract available
    
    
    August 2016
49. ROBERTSON FP, Magill LJ, Wright GP, Fuller B, et al
    A systematic review and meta-analysis of donor ischaemic preconditioning in liver transplantation.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12849.
    PubMed     Text format     Abstract available
    
    
    July 2016
50. PAMECHA V, Mahansaria SS, Kumar S, Bharathy KG, et al
    Association of thrombocytopenia with outcome following adult living donor liver transplantation.
    Transpl Int. 2016 Jul 18. doi: 10.1111/tri.12819.
    PubMed     Text format     Abstract available
    
    
    
51. PITCHAIMUTHU M, Roll GR, Zia Z, Olliff S, et al
    Long-term follow-up after endovascular treatment of hepatic venous outflow obstruction following liver transplantation.
    Transpl Int. 2016 Jul 2. doi: 10.1111/tri.12817.
    PubMed     Text format     Abstract available
    
    
    May 2016
52. BEINHARDT S, Al Zoairy R, Ferenci P, Kozbial K, et al
    DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and post kidney transplantation setting.
    Transpl Int. 2016 May 20. doi: 10.1111/tri.12799.
    PubMed     Text format     Abstract available
    
    
    
53. TESTINO G
    Alcohol and liver transplantation: the six-month abstinence rule is not a dogma.
    Transpl Int. 2016 May 9. doi: 10.1111/tri.12790.
    PubMed     Text format     Abstract available
    
    
    April 2016
54. LEE KW, Lee S, Dong Kyu O, Na BG, et al
    Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Liver Grafts.
    Transpl Int. 2016 Apr 26. doi: 10.1111/tri.12787.
    PubMed     Text format     Abstract available
    
    
    
55. BRANDL A, Stolzlechner P, Eschertzhuber S, Aigner F, et al
    Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
    Transpl Int. 2016;29:471-82.
    PubMed     Text format     Abstract available
    
    
    March 2016
56. TIAN Y, Lesurtel M, Ungethuem U, Song Z, et al
    A novel technique in mouse liver transplantation (with video).
    Transpl Int. 2016 Mar 31. doi: 10.1111/tri.12780.
    PubMed     Text format     Abstract available
    
    
    
57. IJTSMA AJ, van der Hilst CS, Nijkamp DM, Bottema JT, et al
    Does The MELD System Provide Equal Access to Liver Transplantation for Patients with Different ABO Blood Groups?
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12774.
    PubMed     Text format     Abstract available
    
    
    February 2016
58. KOLLMANN D, Rasoul-Rockenschaub S, Steiner I, Freundorfer E, et al
    Good outcome after liver transplantation for ALD without a 6-months abstinence rule prior to transplantation including post-transplant CDT-monitoring for alcohol relapse assessment - a retrospective study.
    Transpl Int. 2016 Feb 10. doi: 10.1111/tri.12756.
    PubMed     Text format     Abstract available
    
    
    
59. ELDEEN FZ, Mourad MM, Bhandari M, Roll G, et al
    Accepting multiple simultaneous liver offers does not negatively impact transplant outcomes.
    Transpl Int. 2016;29:227-33.
    PubMed     Text format     Abstract available
    
    
    January 2016
60. KIVELA JM, Kosola S, Perasaari J, Makisalo H, et al
    Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients.
    Transpl Int. 2016 Jan 25. doi: 10.1111/tri.12747.
    PubMed     Text format     Abstract available
    
    
    
61. ZHONG Z, Ye S, Xiong Y, Wu L, et al
    Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway.
    Transpl Int. 2016;29:98-107.
    PubMed     Text format     Abstract available
    
    
    
62. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available
    
    
    December 2015
63. RODRIGUEZ-PERALVAREZ M, Rico-Juri JM, Tsochatzis E, Burra P, et al
    Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12737.
    PubMed     Text format     Abstract available
    
    
    
64. RUSSO FP, Zanetto A, Burra P
    Timing for treatment of HCV recurrence after liver transplantation: the earlier the better.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12739.
    PubMed     Text format     Abstract available
    
    
    
65. LIESE J, Peveling-Oberhag J, Doering C, Schnitzbauer AA, et al
    A possible role of miRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation.
    Transpl Int. 2015 Dec 23. doi: 10.1111/tri.12733.
    PubMed     Text format     Abstract available
    
    
    
66. GAMBATO M, Crespo G, Torres F, LLovet L, et al
    Simple prediction of long-term clinical outcomes in patients with mild hepatitis c recurrence after liver transplantation.
    Transpl Int. 2015 Dec 11. doi: 10.1111/tri.12730.
    PubMed     Text format     Abstract available
    
    
    November 2015
67. ROBERTSON FP, Bessell PR, Diaz-Nieto R, Thomas N, et al
    High serum Aspartate Transaminase (AST) levels on day 3 post liver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12723.
    PubMed     Text format     Abstract available
    
    
    
68. LIBRIZZI S, Guadalix S, Martinez-Diaz Guerra G, Allo G, et al
    Trabecular bone sc0re in patients with liver transplants after one year of risedronate treatment.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12725.
    PubMed     Text format     Abstract available
    
    
    October 2015
69. DARWISH MURAD S, Metselaar HJ
    The invasion of fatty liver disease in liver transplantation.
    Transpl Int. 2015 Oct 24. doi: 10.1111/tri.12707.
    PubMed     Text format     Abstract available
    
    
    September 2015
70. ALKHOURI N, Hanouneh IA, Zein NN, Lopez R, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Young Patients.
    Transpl Int. 2015 Sep 24. doi: 10.1111/tri.12694.
    PubMed     Text format     Abstract available
    
    
    August 2015
71. ARRIZZA C, De Gottardi A, Foglia E, Baumgartner M, et al
    Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up.
    Transpl Int. 2015 Aug 27. doi: 10.1111/tri.12677.
    PubMed     Text format     Abstract available
    
    
    
72. BELLO AD, Congy-Jolivet N, Danjoux M, Muscari F, et al
    De novo Donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
    Transpl Int. 2015 Aug 25. doi: 10.1111/tri.12654.
    PubMed     Text format     Abstract available
    
    
    
73. O'LEARY JG
    Donor-specific alloantibodies in liver transplantation: How should we define and improve long-term success?
    Transpl Int. 2015 Aug 18. doi: 10.1111/tri.12661.
    PubMed     Text format     Abstract available
    
    
    
74. UEDA Y, Uemoto S
    Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.
    Transpl Int. 2015 Aug 13. doi: 10.1111/tri.12653.
    PubMed     Text format     Abstract available
    
    
    July 2015
75. BURRA P, De Martin E, Zanetto A, Senzolo M, et al
    "HCV and liver transplantation: where do we stand?"
    Transpl Int. 2015 Jul 21. doi: 10.1111/tri.12642.
    PubMed     Text format     Abstract available
    
    
    
76. BHAT M, Hathcock M, Kremers WK, Darwish Murad S, et al
    Portal Vein Encasement Predicts Neoadjuvant Therapy Response in Liver Transplantation for Perihilar Cholangiocarcinoma protocol.
    Transpl Int. 2015 Jul 16. doi: 10.1111/tri.12640.
    PubMed     Text format     Abstract available
    
    
    
77. SPETZLER VN, Goldaracena N, Kaths JM, Marquez M, et al
    High Pre-operative Bilirubin Values Protect Against Reperfusion Injury after Live Donor Liver Transplantation.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12634.
    PubMed     Text format     Abstract available
    
    
    
78. LEVESQUE E, Paugam-Burtz C, Saliba F, Khoy-Ear L, et al
    Fungal complications after Candida preservation fluid contamination in liver-transplant recipients.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12633.
    PubMed     Text format     Abstract available
    
    
    
79. HOUBEN P, Manzini G, Kremer M, Arend J, et al
    Graft rinse prior to reperfusion in liver transplantation: Literature review and online survey within the Eurotransplant community.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12631.
    PubMed     Text format     Abstract available
    
    
    
80. THOMAS MN, Nadalin S, Schemmer P, Pascher A, et al
    A German survey of the abdominal transplantation surgical work force.
    Transpl Int. 2015;28:849-56.
    PubMed     Text format     Abstract available
    
    
    
81. HALDAR D, Chen F, Byron J, Elsharkawy AM, et al
    Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia.
    Transpl Int. 2015;28:881-3.
    PubMed     Text format     Abstract available
    
    
    June 2015
82. BONACCI M, Londono MC, Esforzado N, Forns X, et al
    Antiviral Treatment with Sofosbuvir and Simeprevir in a Kidney-Transplant Recipient with HCV-Decompensated Cirrhosis: Viral Eradication and Removal from the Liver Transplant Waiting List.
    Transpl Int. 2015 Jun 13. doi: 10.1111/tri.12622.
    PubMed     Text format     Abstract available
    
    
    
83. UCHIDA H, Fukuda A, Sasaki K, Miyasaka M, et al
    Donor Double Common Bile Duct in Living Donor Liver Transplantation.
    Transpl Int. 2015 Jun 5. doi: 10.1111/tri.12619.
    PubMed     Text format     Abstract available
    
    
    May 2015
84. BHATTI AB, Dar FS, Zia H
    Where Angels Fear to Tread: Donor Bile Duct Division in Living Donor Liver Transplant.
    Transpl Int. 2015 May 27. doi: 10.1111/tri.12613.
    PubMed     Text format     Abstract available
    
    
    
85. KURAMITSU K, Fukumoto T, Yano Y, Hirano H, et al
    A case of intravascular lymphoma diagnosed in an explanted liver after liver transplantation.
    Transpl Int. 2015 May 23. doi: 10.1111/tri.12611.
    PubMed     Text format     Abstract available
    
    
    March 2015
86. WESTERKAMP AC, de Boer MT, van den Berg AP, Gouw AS, et al
    Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Transpl Int. 2015;28:319-29.
    PubMed     Text format     Abstract available
    
    
    February 2015
87. WATT KD
    Is 40 the new 30?
    Transpl Int. 2015;28:146-7.
    PubMed     Text format    
    
    
    
88. TRIPON S, Francoz C, Albuquerque A, Paradis V, et al
    Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.
    Transpl Int. 2015;28:162-9.
    PubMed     Text format     Abstract available
    
    
    August 2014
89. INDOLFI G, Berczes R, Pelliccioli I, Bosisio M, et al
    Neonatal haemochromatosis with reversible pituitary involvement.
    Transpl Int. 2014;27:e76-9.
    PubMed     Text format     Abstract available
    
    
    May 2014
90. ALMEIDA-PAULO GN, Lubomirov R, Alonso-Sanchez NL, Espinosa-Roman L, et al
    Limited Sampling Strategies For Tacrolimus Exposure (Auc ) Prediction After Prograf And Advagraf Administration In Children And Adolescents With Liver Or Kidney Transplants.
    Transpl Int. 2014 May 27. doi: 10.1111/tri.12362.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: